Patent · US Active

Synthetic single domain antibody

US11014977B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
INSTITUT CURIE · FR
UNIVERSITE PAUL SABATIER—TOULOUSE III · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Aurelien Olichon · Toulouse, FR
Sandrine Moutel · Paris, FR
Franck Perez · Paris, FR

Key dates

Filing date	Jun 25, 2018
Grant date	May 25, 2021
Priority date	—
Expiry date	Apr 13, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC40B50/06
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to the identification of a highly stable single domain antibody scaffold (hs2dAb) and its use in generating synthetic single domain antibody library (hs2dAb-L1). The invention also relates to antigen-binding proteins comprising said stable single domain antibody scaffold and their uses, in particular as therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.